| |
Partnership to expand ecosystem connectivity, expertise access, and enablement for life sciences companies
SINGAPORE, April 9, 2026 /PRNewswire/ -- NSG Bio announced the signing of a Memorandum of Understanding (MOU) with Charles River Laboratories ("Charles River"), marking a new collaboration aimed at strengthening support for biotech companies building and scaling in Singapore. The MOU was signed during Charles River's APAC Biomanufacturing Leadership Summit 2026, reflecting a shared commitment to accelerating innovation through stronger connections across the life sciences value chain.
The partnership brings together NSG Bio's purpose-built infrastructure and community platform with Charles River's global life sciences expertise, with the goal of enabling companies to move more efficiently from early research toward key development milestones. Charles River's expertise in Cell Banking, Cell Line Characterization, Protein Characterization and many other testing capabilities brings value to the biotech ecosystem.
"From the beginning, NSG Bio's main goal has always been simple but important: to empower the biotech community, not only within NSG Bio but also across the broader Singapore ecosystem. We aim to create an environment where scientists and startups have the infrastructure, resources, and support they need to turn ideas into impactful innovations.
With the signing of this Memorandum of Understanding with Charles River, we are taking another meaningful step forward. As a leading scientific partner providing a wide range of research and laboratory products and services, Charles River brings tremendous expertise and capabilities to the table. Through this collaboration, NSG BioLabs will be better positioned to support our community end-to-end from infrastructure and tools to specialized services, products, and scientific expertise," said Hasyim Sim, Chief Operating Officer, NSG Bio.
"We are excited to deepen our partnership with NSG Bio as we continue to support the growth of the biotech industry in Singapore," said Kerstin Dolph, Senior Vice President, Manufacturing, Charles River. "Utilizing our biologics expertise, we help organizations become more efficient as they move from initial research to key development milestones."
Strengthening Singapore's Biotech Ecosystem
Singapore's life sciences sector continues to attract innovative startups and global industry players. As companies scale, they face increasing complexity across development planning, operational readiness, and execution. NSG Bio and Charles River intend to collaborate on initiatives that help reduce friction for companies and strengthen pathways between early R&D and downstream development activities.
Under the MOU, the parties will explore opportunities including:
- Ecosystem enablement initiatives for biotech companies, like shared learning sessions
- A wide range of characterization and testing capabilities
- Knowledge exchange and access to expertise across relevant scientific and industry domains
- Opportunities to connect startups with partners and resources that support efficient development and scaling
Additional details on specific initiatives will be shared in due course.
About NSG Bio
Founded with a focus on supporting biotech innovation, NSG Bio offers state-of-the-art equipment, efficient operations, capital efficiency, the expertise of world-class teams and global networks to assist life sciences companies. The conducive R&D environment contains fully-equipped, certified BSL-2 laboratory and office infrastructure across 70,000 sq ft within Singapore's biomedical science clusters, Biopolis and Singapore Science Park.
By providing access to high-quality infrastructure, its extensive partner network, community, and value-add benefits, NSG Bio ensures that companies, ranging from emerging biotech startups to multinational companies, can rapidly and efficiently execute their cutting-edge research and development ecosystem in Singapore, leading to the innovation of revolutionary technologies and products that translate into breakthrough biotech ventures and impact for patients. For more information, visit www.nsgbio.com
Media Contacts
NSG Bio
Email: info@nsgbio.com
Website: www.nsgbio.com
Phone: +65 6970 4660
Partnership to expand ecosystem connectivity, expertise access, and enablement for life sciences companies
SINGAPORE, April 9, 2026 /PRNewswire/ -- NSG Bio announced the signing of a Memorandum of Understanding (MOU) with Charles River Laboratories ("Charles River"), marking a new collaboration aimed at strengthening support for biotech companies building and scaling in Singapore. The MOU was signed during Charles River's APAC Biomanufacturing Leadership Summit 2026, reflecting a shared commitment to accelerating innovation through stronger connections across the life sciences value chain.
The partnership brings together NSG Bio's purpose-built infrastructure and community platform with Charles River's global life sciences expertise, with the goal of enabling companies to move more efficiently from early research toward key development milestones. Charles River's expertise in Cell Banking, Cell Line Characterization, Protein Characterization and many other testing capabilities brings value to the biotech ecosystem.
"From the beginning, NSG Bio's main goal has always been simple but important: to empower the biotech community, not only within NSG Bio but also across the broader Singapore ecosystem. We aim to create an environment where scientists and startups have the infrastructure, resources, and support they need to turn ideas into impactful innovations.
With the signing of this Memorandum of Understanding with Charles River, we are taking another meaningful step forward. As a leading scientific partner providing a wide range of research and laboratory products and services, Charles River brings tremendous expertise and capabilities to the table. Through this collaboration, NSG BioLabs will be better positioned to support our community end-to-end from infrastructure and tools to specialized services, products, and scientific expertise," said Hasyim Sim, Chief Operating Officer, NSG Bio.
"We are excited to deepen our partnership with NSG Bio as we continue to support the growth of the biotech industry in Singapore," said Kerstin Dolph, Senior Vice President, Manufacturing, Charles River. "Utilizing our biologics expertise, we help organizations become more efficient as they move from initial research to key development milestones."
Strengthening Singapore's Biotech Ecosystem
Singapore's life sciences sector continues to attract innovative startups and global industry players. As companies scale, they face increasing complexity across development planning, operational readiness, and execution. NSG Bio and Charles River intend to collaborate on initiatives that help reduce friction for companies and strengthen pathways between early R&D and downstream development activities.
Under the MOU, the parties will explore opportunities including:
- Ecosystem enablement initiatives for biotech companies, like shared learning sessions
- A wide range of characterization and testing capabilities
- Knowledge exchange and access to expertise across relevant scientific and industry domains
- Opportunities to connect startups with partners and resources that support efficient development and scaling
Additional details on specific initiatives will be shared in due course.
About NSG Bio
Founded with a focus on supporting biotech innovation, NSG Bio offers state-of-the-art equipment, efficient operations, capital efficiency, the expertise of world-class teams and global networks to assist life sciences companies. The conducive R&D environment contains fully-equipped, certified BSL-2 laboratory and office infrastructure across 70,000 sq ft within Singapore's biomedical science clusters, Biopolis and Singapore Science Park.
By providing access to high-quality infrastructure, its extensive partner network, community, and value-add benefits, NSG Bio ensures that companies, ranging from emerging biotech startups to multinational companies, can rapidly and efficiently execute their cutting-edge research and development ecosystem in Singapore, leading to the innovation of revolutionary technologies and products that translate into breakthrough biotech ventures and impact for patients. For more information, visit www.nsgbio.com
Media Contacts
NSG Bio
Email: info@nsgbio.com
Website: www.nsgbio.com
Phone: +65 6970 4660
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
NSG Bio and Charles River Sign Memorandum of Understanding to Strengthen Support for Biotech Innovation in Singapore
HONG KONG, April 9, 2026 /PRNewswire/ -- INCUBASE Studio announced its entry into the South Korean market through a strategic partnership with Korea-listed media technology company Dotmill, alongside the launch of INCUBASE Arena Jeju — set to become the largest INCUBASE Arena to date. Scheduled to open this year, the project marks a key milestone in the company's global expansion and the new phase of anime and IP-based experiential entertainment.
Over the past year, INCUBASE Studio has established a foundation in Korea through exhibitions such as "The Animation Chainsaw Man Exhibition", "Tokyo Revengers Exhibition", "Oshi no Ko Exhibition" and "The iDOLM@STER: Cinderella Girls Exhibition", demonstrating strong demand for immersive, IP-driven experiences.
A Cultural Tourism Destination and Strategic Bridge
INCUBASE Arena Jeju will serve as both an entertainment venue and a cultural tourism destination, reflecting the shift from static exhibitions to immersive anime experiences and experience-led travel. The development also anchors INCUBASE Studio's "two-way bridge" strategy, introducing global IP exhibitions into Korea while exporting Korean content (K-Content) to its international Arena network.
"This is not simply about entering a new market," said Sion Yip, Founder and CEO of INCUBASE Studio. "It is about building a platform that connects cultures through shared experiences. INCUBASE Arena Jeju will serve as our prototype as we expand beyond Asia into Western markets."
Sustaining Momentum Across the INCUBASE Arena Network
Across its network, INCUBASE Arena operates as an anime cultural and experience hub, maintaining fan engagement through a pipeline of exhibitions and pop-up experiences.
In Hong Kong, recent highlights include "The Apothecary Diaries Exhibition" and "Demon Slayer: Infinity Castle Pop-up Store", alongside the ongoing "Masked Rider Kuuga 25th Anniversary Exhibition". Pop-up activations have featured fan-favourites including My Hero Academia, JoJo's Bizarre Adventure, Super Sentai, Yu-Gi-Oh! Duel Monsters, Puella Magi Madoka Magica, Code Geass: Lelouch of the Rebellion, and 86 EIGHTY-SIX.
INCUBASE Arena Malaysia has brought fans closer to their beloved IPs with events like the "Digimon Adventure Anime 25th Anniversary Exhibition" and the "Crayon Shinchan: Space & Time Adventure Interactive Exhibition" running alongside a themed café experience. "The Apothecary Diaries Exhibition" is set to launch in May, continuing the venue's strong lineup. Meanwhile, INCUBASE Arena Taipei keeps fans returning with activations, including Dating Game, Twittering Birds Never Fly, Initial D, and My Hero Academia, with the Nintama Rantarō pop-up store set to open next.
"We aim to connect with fans across Asia and beyond, creating spaces where people can come together to share and celebrate their passion," added Sion.
Building the Future of Anime Experience
With the launch of INCUBASE Arena Jeju, INCUBASE Studio is expanding a connected network of anime experience hubs across Asia and beyond, creating spaces where IP can be continuously experienced and shared, and reinforcing its position at the forefront of the global anime experience economy.
About INCUBASE Studio
INCUBASE Studio creates and curates immersive, IP-themed exhibitions and experiences that connect fandoms worldwide. Bringing beloved characters and stories to life through captivating storytelling, interactive installations and engaging fan experiences, the Studio pushes the boundaries of physical venues across Asia and beyond with its Touring Experiences.
The Studio has established INCUBASE Arena in Hong Kong, Kuala Lumpur and Taipei — dedicated hub for anime culture and experiences, combining exhibitions, pop-up stores, exclusive merchandise, themed cafés and anime events through ongoing collaborations with popular IPs. With further expansion across Asia, Europe and America, INCUBASE Arena builds vibrant fan communities while bringing anime culture to a global stage.
www.incubasestudio.com
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
INCUBASE Studio Enters Korea with Its Largest INCUBASE Arena in Jeju, Creating a New Anime Cultural Destination
